PetMed Express (PETS) Set to Announce Earnings on Wednesday

PetMed Express (NASDAQ:PETS - Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Persons that are interested in participating in the company's earnings conference call can do so using this link.

PetMed Express (NASDAQ:PETS - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.30. PetMed Express had a negative net margin of 1.24% and a negative return on equity of 3.44%. The firm had revenue of $67.95 million during the quarter, compared to analyst estimates of $77.52 million. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Price Performance

Shares of PETS traded down $0.05 during midday trading on Wednesday, hitting $4.03. The stock had a trading volume of 143,567 shares, compared to its average volume of 334,372. The firm has a market cap of $83.02 million, a price-to-earnings ratio of -23.71 and a beta of 0.71. The company has a 50 day simple moving average of $3.62 and a two-hundred day simple moving average of $3.87. PetMed Express has a twelve month low of $2.90 and a twelve month high of $8.27.

Analyst Ratings Changes

Separately, Lake Street Capital reaffirmed a "hold" rating and set a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a research report on Wednesday, August 7th.

Insider Activity

In related news, major shareholder Nina Capital Holdings Inc. bought 12,500 shares of the company's stock in a transaction that occurred on Monday, September 9th. The shares were acquired at an average price of $3.34 per share, for a total transaction of $41,750.00. Following the completion of the acquisition, the insider now owns 2,078,000 shares of the company's stock, valued at approximately $6,940,520. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.10% of the stock is owned by corporate insiders.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.